They may missed to update the table?
I know it's unprofessional, and looks confusing, but definitely looks different to the previous Sep announcement.
From the Sep announcement, they reported as ( 2 ORR = 2 CR ) + 1 Stable disease + 1 awaiting evaluation out of 4.
This time, it reported on the table as 3 ORR / 2CR ( maybe mistake?? ) + 1 ongoing response out of 4.
'IL-2 markedly improved CAR T expansion (Figure 1) without impacting safety, with 3 CRs reported in 4 evaluable patients, and 1 with ongoing response past 120 days.
Fingers crossed.
Ann: Azer-cel Accepted for Presentation at ASTCT Tandem Meetings, page-199
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $112.0M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.4¢ | $49.10K | 3.388M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 79 | 19329478 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 4763326 | 25 |
View Market Depth
| Last trade - 12.33pm 16/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |